| Literature DB >> 30457078 |
Evelien T Wolf1, Wouter D Weeda2, Roland B Wetzels3, Jos F M de Jonghe4, Raymond C T M Koopmans3.
Abstract
OBJECTIVES: To adequately monitor the course of cognitive functioning in persons with moderate to severe dementia, relevant cognitive tests for the advanced dementia stages are needed. We examined the ability of a test developed for the advanced dementia stages, the Severe Impairment Battery Short version (SIB-S), to measure cognitive change over time. Second, we examined type of memory impairment measured with the SIB-S in different dementia stages.Entities:
Keywords: Cognition; Cognitive decline; Dementia; Dementia stages; Institutionalization; Longitudinal studies; Neuropsychological tests
Mesh:
Year: 2018 PMID: 30457078 PMCID: PMC6390392 DOI: 10.1017/S1355617718000991
Source DB: PubMed Journal: J Int Neuropsychol Soc ISSN: 1355-6177 Impact factor: 2.892
SIB-S items per subscale
| Item number | Score |
|---|---|
|
| |
| 1. Shake hands | 0, 1, 2 |
| 2. Follow directions | 0, 1, 2 |
|
| |
| 3. Immediate recall of examiner’s name | 0, 1, 2 |
| 12. Delayed recall of examiner’s name | 0, 1, 2 |
| 21. Recall of coloured block | 0, 1, 2 |
| 25. Delayed recall of cup | 0, 1 |
|
| |
| 4. Subject’s name | 0, 1, 2 |
| 7. City name | 0, 1, 2 |
|
| |
| 5. Write name | 0, 1, 2 |
| 6. Copy name | 0, 1, 2 |
| 8. Responsive naming – cup | 0, 1, 2 |
| 9. Reading comprehension | 0, 1, 2 |
| 10. Verbal comprehension | 0, 1, 2 |
| 13. Confrontational naming – cup | 0, 1, 2 |
| 15. Object naming – cup | 0, 1, 2 |
| 17. Forced choice naming – cup | 0, 1 |
| 18. Confrontational naming – spoon | 0, 1, 2 |
| 19. Color naming – blue | 0, 1, 2 |
| 23. Color naming – red | 0, 1, 2 |
|
| |
| 11. Digit span | 0, 1, 2 |
|
| |
| 14. Using cup – photograph | 0, 1, 2 |
| 16. Using cup – cup | 0, 1, 2 |
|
| |
| 20. Color matching | 0, 1, 2 |
| 22. Color discrimination | 0, 1, 2 |
|
| |
| 24. Drawing – square | 0, 1, 2 |
|
| |
| 26. Orienting to name | 0, 1, 2 |
Subtypes of dementia for the whole sample
| Subtype |
|
|---|---|
| Possible/probable AD | 82 |
| Possible/probable VaD | 24 |
| Mixed AD/VaD | 11 |
| Mixed AD/not otherwise specified | 8 |
| Mixed VaD/not otherwise specified | 2 |
| Mixed VaD/Dementia with Lewy Bodies | 2 |
| Mixed VaD/Parkinson’s Dementia/not otherwise specified | 1 |
| Mixed Dementia with Lewy Bodies/not otherwise specified | 1 |
| Mixed Frontotemporal Dementia/not otherwise specified | 1 |
| Mixed Parkinson’s Dementia/not otherwise specified | 1 |
| Dementia with Lewy Bodies | 4 |
| Frontotemporal Dementia | 4 |
| Parkinson’s Dementia | 1 |
| Not otherwise specified | 75 |
AD, Alzheimer’s disease; VaD, vascular dementia.
Baseline characteristics of the sample
| Baseline characteristics | Total sample ( | GDS-score 5 ( | GDS-score 6 ( | GDS-score 7 ( |
|
|
|---|---|---|---|---|---|---|
| Age in years | ||||||
| Mean ( | 83.91 (6.82) | 83.89 (6.44) | 83.35 (6.43) | 85.13 (7.97) | .274 |
|
| Median | 84.47 | 84.76 | 83.78 | 85.82 | ||
| Range | 59.30–102.20 | 59.30–97.62 | 60.51–96.58 | 65.51–102.20 | ||
| Gender, men (%) | 23.5 | 30.5 | 23.1 | 16 | .216 |
|
| Education (%) | .284 |
| ||||
| Primary | 26.3 | 20.3 | 24.1 | 38 | ||
| Low vocational secondary | 19.4 | 20.3 | 21.3 | 14 | ||
| Mid vocational secondary | 6.9 | 6.8 | 8.3 | 4 | ||
| High vocational secondary | 2.3 | 5.1 | 1.9 | 0 | ||
| University | .9 | 0 | .9 | 2 | ||
| Missing values | 44.2 | 47.5 | 43.5 | 42 | ||
| Years in nursing home |
|
|
|
| <.001 |
|
| Mean ( | 2.69 (2.01) | 2.15 (2.00) | 2.57 (1.96) | 3.55 (2.05) | ||
| Median | 2.06 | 1.59 | 1.96 | 3.61 | ||
| Range | .10–10.28 | .12–10.28 | .18–9.08 | .10–8.27 | ||
| Years in nursing home unit |
|
|
|
| <.001 |
|
| Mean ( | 2.36 (1.94) | 1.80 (1.84) | 2.22 (1.84) | 3.32 (1.95) | ||
| Median | 1.81 | 1.16 | 1.71 | 2.78 | ||
| Range | .05–10.28 | .05–10.28 | .17–9.08 | .10–7.57 | ||
| Medication use (%) | ||||||
| Antipsychotic | 35.0 | 32.2 | 32.4 | 44.0 | .332 |
|
| Antidepressant | 27.6 | 22 | 31.5 | 26.0 | .412 |
|
| Hypnotic | 13.8 | 13.6 | 14.8 | 12.0 | .935 |
|
| Anxiolytic | 18.4 | 15.3 | 17.6 | 24.0 | .492 |
|
| NMDA inhibitor | 5.5 | 8.5 | 4.6 | 4.0 | .586 |
|
| ADL dependency | ||||||
| Independent | 2.3 | 5.1 | 1.9 | 0 | <.001 |
|
| Supervision | 12 | 28.8 | 8.3 | 0 | ||
| Limited | 6.9 | 8.5 | 9.3 | 0 | ||
| Extensive 1 | 33.6 | 35.6 | 38.9 | 20.0 | ||
| Extensive 2 | 6.0 | 5.1 | 5.6 | 8.0 | ||
| Dependent | 27.2 | 16.9 | 27.8 | 38.0 | ||
| Total dependence | 12.0 | 0 | 8.3 | 34.0 | ||
| MMSE |
|
|
|
| <.001 |
|
| Mean ( | 7.19 (6.06) | 13.08 (4.79) | 6.75 (4.74) | 1.02 (1.93) | ||
| Median | 7 | 13 | 7 | 0 | ||
| Range | 0-24 | 1-24 | 0–17 | 0–7 | ||
| SIB-S | ||||||
| Mean ( | 27.50 (15.48) | 40.44 (7.04) | 29.49 (12.12) | 7.94 (8.74) | <.001 |
|
| median | 31 | 42 | 32 | 4.5 | ||
| range | 0–50 | 16–50 | 0–48 | 0–32 | ||
Note. GDS-score 5, moderate dementia; GDS-score 6, moderately severe dementia; GDS-score 7, severe cognitive decline/late dementia; p-value, results of the Pearson χ²-test for gender, education, medication use, ADL dependency, and Independent Samples Kruskal-Wallis Test for age, years in nursing home (unit), MMSE-score, and SIB-S score to compare between GDS-scores; η, eta squared, effect size for Independent Samples Kruskal-Wallis Test; V, Cramer’s V, effect size for Pearson ‘s χ²-test.
N/n, number of participants; SD, standard deviation; MMSE, Mini-Mental State Examination; SIB-S, Severe Impairment Battery Short version.
Growth curve models for SIB-S total and domain scores
| Total SIB-S | Semantic memory | Episodic memory | M-O-ATT | |
|---|---|---|---|---|
|
| ||||
| Fixed effects (coefficients and | ||||
| Constant | 27.902(1.073) | 17.122(.734) | 1.555(.096) | 6.199(.264) |
| Age (centered) | .041 (.155) | .030(.105) | −.018(.013) | .008(.038) |
| Time (days from T0) | −.012(.001) | −.008(.001) | −.0008(.0002) | −.002(.0003) |
|
| ||||
| Fixed effects (coefficients and | ||||
| Constant | 27.748(1.082) | 17.060(.740) | 1.499(.099) | 6.157(.268) |
| Age (centered) | .042(.155) | .030(.105) | −.018(.013) | .008(.038) |
| Time (days from T0) | − .009(.003) | −.006(.002) | .0002(.0005) | −.002(.001) |
| Time² | <−.0001(<.0001) | < .0001(<.0001) | < .0001(<.0001) | < .0001(<.0001) |
|
| ||||
| Fixed effects (coefficients and | ||||
| Constant | 29.896(.999) | 18.369(.713) | 1.558(.110) | 6.523(.257) |
| Age (centered) | .171(.102) | .113(.072) | −.010(.010) | .042(.026) |
| Time (days from T0) | −.018(.002) | −.012(.001) | −.001(.0002) | −.004(.0006) |
| GDS (6 compared to 5) | 11.434(1.673) | 7.705(1.194) | 1.126(.184) | 3.062(.431) |
| GDS (6 compared to 7) | −21.970(1.774) | −14.380(1.267) | −1.334(.196) | −4.903(.457) |
| GDS (7 compared to 5) | 33.404(1.984) | 22.086(1.417) | 2.460(.218) | 7.966(.512) |
| GDS (6 compared to 5) × Time | .009(.003) | .006(.002) | .0002(.0004) | .001(.0009) |
| GDS (6 compared to 7) × Time | .013(.003) | .009(.002) | .0009(.0004) | .003(.0009) |
| GDS (7 compared to 5) × Time | −.004(.004) | −.003(.003) | −.0007(.0004) | −.002(.001) |
|
| ||||
| Fixed effects (coefficients and | ||||
| Constant | 41.330(.910) | 26.033(.693) | 2.682(.152) | 9.591(.259) |
| Age (centered) | −.127(.134) | −.079(.097) | −.048(.021) | −.042(.038) |
| Time (days from T0) | −.008(.003) | −.004(.002) | −.0008(.0003) | −.002(.0007) |
|
| ||||
| Fixed effects (coefficients and | ||||
| Constant | 30.046(1.177) | 18.472(.848) | 1.570(.127) | 6.560(.297) |
| Age (centered) | .421(.181) | .293(.130) | .011(.018) | .103(.045) |
| Time (days from T0) | −.018(.002) | −.012(.002) | −.001(.0003) | −.004(.0007) |
|
| ||||
| Fixed effects (coefficients and | ||||
| Constant | 8.045(1.271) | 4.071(.789) | .210(.066) | 1.643(.324) |
| Age (centered) | .031(.154) | .011(.095) | −.008(.007) | .012(.039) |
| Time (days from T0) | −.004(.001) | −.002(.001) | −.0002(.0002) | −.0007(.0005) |
Note. GDS-score 5, moderate dementia; GDS-score 6, moderately severe dementia; GDS-score 7, severe cognitive decline/late dementia
Group with GDS-score 6 was used as reference group.
p < .05.
p < . 01.
p < .001.
SIB-S, Severe Impairment Battery Short version; M-O-ATT, Memory-Orientation-Attention domain.
Mean SIB-S scores on successive assessments for the whole sample
|
| Mean (SD) | Range | |
|---|---|---|---|
| T0 | 217 | 27.50 (15.48) | 0–50 |
| T1 | 149 | 26.81 (17.61) | 0–50 |
| T2 | 117 | 23.49 (18.03) | 0–50 |
| T3 | 92 | 20.97 (17.66) | 0–49 |
| T4 | 70 | 19.93 (18.99) | 0–50 |
N, number of participants; SD, standard deviation.
Fig. 1Course of SIB-S scores over time for persons with moderate to severe dementia according to dementia stage (without a correction for age). The bold lines represent the mean course of SIB-S scores per GDS-score and the thin lines represent the course of SIB-S scores for each individual participant.
Fig. 2Ranking of the items by how many participants could still successfully complete the item. As a measure for the items completion rate, per item the mean normalized SIB-S score was calculated. The average (represented by bullets) and associated standard deviation (represented by lines) were taken over all participants and all tests.
Fig. 3Ranking of the items by how many participants could still successfully complete the item per group (classified by total SIB-S score). The ranking was based on the whole population. As a measure for the item’s completion rate, per item the mean normalized SIB-S score was calculated per group. The mean normalized SIB-S score was calculated by taking the average (represented by bullets) and associated standard deviation (represented by lines) over all participants within one group.